Antares Pharma, Inc ATRS

MarketMoversReport

ATRS: Antares Pharma, Inc. 2022-03-29 07:00:00 Antares Pharma Announces FDA Approval Of TLANDO™, an Oral Treatment for Testosterone Replacement Therapy

RocketTickers

ATRS: Antares Pharma, Inc. 2022-01-11 07:30:00 Antares Pharma Announces Positive Results From Phase I Study For ATRS-1902 For Adrenal Crisis Rescue

UnknownUnicorn15971747

$ATRS (Fundamental and Technical Analysis) - looks very bullish for Short-term and Intermediate Term. - Current Price: $4.43 - One Year Price Target: $6.5 - EPS This Year: 83% - Next Year Expected EPS: 130% - Strong Buy Recommendations on Morningstar, Barchart and AmericanBulls.

JM_2021 Pro+

Monthly chart/ ready to breakout

OrangeTrader93 Pro

ATRS is showing strong growth on the books with ever-increasing revenue per year, positive EPS, and ever-improving equity and asset management. The 10 years discounted cash flows model indicates that the company's stock is currently undervalued at between $4.39 and $5.64 (26.9% - 63%) Technical analysis indicates that bulls have oversaturated the market and we...

maschera

Approach this with extra-care, allocate less than usual, and take profit fast. This is a penny stock and a high-risk / high-reward scenario. Clear 6-month uptrend Support with a Bullish Pennant formed within. Target price set at a new potential resistance line. I suggest entering a Buy Stop order. If the stop price is not triggered, I wouldn't try to chase a...

DorofeevML

ATRS

InsiderFinancial Premium

It's been 2 years since $ATRS was last above $4 a share. Might be some fireworks next week. Antares Pharma, Inc. (ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Ladenburg Thalmann 2019 Healthcare Conference on Tuesday, September 24, 2019 at 12:00 p.m. Eastern Time. About Antares Pharma Antares Pharma,...

LionGate

Hello Successful Trader, The stock (ATRS) appears to be presenting heavy consolidation within the price level (0.05 - 5.70). Considering the (Pre-Market) earnings release, there may be sufficient (catalyst) to infiltrate either Resistance Level 1 or Support Level 1 (Await Price Action Confirmation). The overall trend of the market appears to be manifesting a...

Paradox155

Think It will rebound eventually.

akillam1

We need to be careful with ATRS due to this exponential rise. This has formed a bubble and if that bubble pops it will get ugly as this settles back to trend support. But, this has plenty of space to run to get back to the high before the huge drop months ago. This has been extremely bullish for weeks now. I'd personally like to see a little more consolidation...

bluff1919

long

Evan_Moe_Money

Here I have found another nice chance for a breakout. -Stochastic says the price is close to overbought -descending triangle points to a breakdown -The EMA 200 is ranging with the price, so no good help here. Safe trades to all of you!

michaeltlowe

ATRS at double top waiting on move either way.

isooner4545

Trading well within support resistance rang -- will pullback and then extend through the extended resistance line

ehan

Sitting at a crucial point now. Current range in between 2.4 - 2.5. Reversal might happen however signal appears to be weakish, would like a strong confirmation tomorrow If ATRS breaks below the range, it's going to have a hard time coming back up

Investopedia

Antares Pharma Inc. (ATRS) develops and markets injector solutions for a variety of self-administered therapies. It rallied sharply off the December 2008 bear market low at 29-cents, reaching an all-time high at $5.58 in July 2012. The subsequent downtrend finally ended at 67-cents in March 2016, giving way to a channeled uptick that remains in force more than...

cantestogo

ATRS has broken the uptrend with a strong impulse. I'm looking for a potential bounce before one more wave down. Bearish divergence on 4h chart.